Committed Capital

Every deal document tells a story, and in an antitrust merger review, overbroad and imprecise language can cost months of investigation and millions of dollars in legal fees. In this Committed Capital episode, Dechert antitrust attorneys Rani Habash, Brian Hanna and Greg Luib draw on their combined experience at the firm, the FTC and the DOJ to break down the "hot documents" that attract...

The U.S. Congress has extended Medicare telehealth coverage through 2027, changing the calculus for telehealth deals in several concrete ways. In this Sidecar, Healthcare Transactional Practice co-heads Markus Bolsinger and Jennifer Hutchens and associate Brooke Meadowcroft discuss the principles that will help investors act on the opportunities brought by this increased deal window while also bui...

In this Sidecar, Dechert partners Jarlath Pratt, Clemens York and Mike Okkonen break down the European Commission's proposed Industrial Accelerator Act and its implications for foreign direct investment in the EU's emerging strategic sectors, including batteries, solar, EVs, and critical raw materials. The draft IAA proposes a mandatory pre-closing notification regime with strict conditi...

With buyout and exit values climbing, GPs are leaning in — despite shifting U.S. trade policy, European political stasis and geopolitical uncertainty. On Dechert’s Committed Capital, Everstone Group's Sujoy Bose, Investcorp’s Daniel Lopez-Cruz and Ridgemont Equity Partners’ Dan Harknett join Dechert’s Markus Bolsinger, Sabina Comis, Maria Tan Pedersen and Nick Tomlinson to discuss 2026 opport...

Will your next deal trigger a state “mini-HSR” (Hart-Scott-Rodino) filing? In this episode of Committed Capital Sidecar, Dechert partner James Fishkin unpacks the rise of state mini-HSR premerger filing laws under the Uniform Antitrust Premerger Notification Act – who must file, the key nexus thresholds and what materials must be submitted. He spotlights Washington and Colorado’s early adoption, o...

How will Medicare’s telehealth back-and-forth – and new developments like the 10-year CMS ACCESS Model – reshape the investor playbook? Markus Bolsinger, co-head of Dechert’s global private equity practice, joins Dechert partner Jennifer Hutchens and associate Brooke Meadowcroft to unpack shifts from pandemic-era expansion to the October 1, 2025 “telehealth cliff” and reinstatement through January...

How might Oregon’s new laws restricting private equity in healthcare operations affect regulations in other states, and what should investors and healthcare providers know about them? In the debut edition of Committed Capital’s PE Rx series examining the intersection of PE and healthcare, Dechert partners Markus Bolsinger and Jennifer Hutchens unpack the history and impact of Oregon’s SB 951 and H...

Earlier this month, a U.S. executive order was signed to broaden the availability of alternative asset investments for individuals with 401(k) plans. In this Sidecar episode of our Committed Capital podcast, Dechert partners Bill Bielefeld and Steve Rabitz dive into the challenges fiduciaries face under ERISA and the regulatory shifts poised to redefine retirement investment strategies moving forw...

Despite a year of geopolitical volatility and economic uncertainty, private equity demonstrated its resilience in 2024. With challenges still ahead, how are PE managers setting themselves up for success in the coming year? In this special episode, Dechert partners Sarah Kupferman, Rani Habash, Eliot Relles and Sam Whittaker share their perspectives and insights on key findings from Dechert’s 2025...

The FTC’s recent overhaul of its premerger notification requirements has culminated in a completely new HSR form, which recently became effective and now obligates parties to reportable transactions to disclose substantially more information to the antitrust agencies up front.  What impact will these new requirements have on private equity firms now that they are in effect? In this Sidecar episode...

Private equity firms are increasingly looking at strategic options both for their business and fundraising, including GP-stake sales and seeding transactions. What factors do GPs consider when evaluating these options? In this episode, Dechert’s Sam Kay leads a discussion with Rede Partners’ Magnus Goodlad and New Catalyst Strategic Partners’ Demetrius Sidberry on how the market is developing, how...

2024 marks the 40th anniversary of Dechert’s global private equity practice. In this special episode, Blackstone’s Christopher James, KKR’s John Park, and AB Private Credit Investors’ Jay Ramakrishnan join Ken Young, co-chair of Dechert 's corporate and securities practice and co-head of the global private equity group, to reflect on the evolution of the PE industry, from its humble beginning...

The new EU Foreign Subsidies Regulation (FSR) aims to address potential market distortions caused by subsidies from outside the EU, introducing new European Commission reporting obligations for private equity firms. In this Sidecar, Dechert partners Saira Henry, Michael Okkonen, and Clemens York discuss how private equity firms can adopt proactive strategies and thorough due diligence to effective...

Despite evaluating fewer transactions for potential national security risks, the Committee on Foreign Investment in the United States (CFIUS) is taking longer than ever to complete its reviews, significantly impacting deal closing timelines for PE transactions involving foreign investors. In this Sidecar episode, Dechert private equity partner Bernardo Piereck and national security partners Jeremy...

On the back of a record-setting 2023, the secondary market delivered estimated volumes surpassing US$110 billion. The momentum for credit secondaries shows no sign of slowing down in 2024, but what are the key drivers and trends fueling its growth? In this episode, Dechert’s Nicole Macarchuk leads a discussion with Apollo’s Olga Kosters on how the secondaries market has evolved in recent years, th...

A year of rising interest rates and slower growth has proved challenging for the global PE industry. Yet, notwithstanding a decline in fundraising and dealmaking over the past year, how are resilient managers overcoming today’s challenges and setting themselves up for success during 2024? In this special episode of Committed Capital, private capital and PE leaders from Hamilton Lane , Tikehau Capi...

In recent years, the food and agricultural sector has seen growing interest from private equity investment. Driven by an increased demand for food, environmental, social and governance issues, as well as an awareness of climate change, investor interest in sustainable agriculture is set to continue and grow. What are the key drivers behind this trend? In this episode, Dechert’s Nick Marchica leads...

The U.S. Corporate Transparency Act (CTA) and its new reporting regime take effect on January 1, 2024. In this episode of Committed Capital Sidecar, private equity partners Sarah Kupferman and Greg Schernecke provide an update on its implementation. The CTA’s rules will impact corporations, LLCs, partnerships and other entities and vehicles that exist on January 1, 2024, or are created or register...

The FTC has proposed a complete overhaul of filings related to the Hart-Scott-Rodino (HSR) Act. In this episode of Committed Capital Sidecar, Dechert's James Fishkin , Rani Habash and Beverly Ang discuss the key proposals likely to impact private equity firms and deal timing.

President Biden signed a highly anticipated Executive Order on August 9 to establish the foundation for a U.S. outbound investment regime. In this podcast, Dechert national security partners Jeremy Zucker, Darshak Dholakia and Hrishikesh Hari examine the Biden Administration’s proposal and related considerations for the private equity community.

Banks have reduced their lending activities to private companies of all sizes over the last 10 to 15 years and bank regulators have continued to pressure banks to remain on the sidelines in this lending market. Private credit providers have not only stepped in to fill this void, they have also significantly grown their share of the large company lending market. This explosive boom in private lendi...

In recent months, debt financing for new acquisitions and recapitalizations has become more difficult to source. When available, it is also more expensive and subject to stringent conditions amid continued macroeconomic challenges and prolonged high interest rates. Where does PE financing stand and what does the current challenging market mean for the future deal dynamics?  In this episode, Decher...

Today’s distressed market faces headwinds as a result of macro uncertainty, rising inflation and increasing financing costs. What are the opportunities and challenges for private equity investors and their investment strategies in the current environment? In this episode, Dechert’s Stephen Zide leads a discussion with Kevin O'Neill of KKR and Michael Schwartz of SVPGlobal on the latest develo...

In this Sidecar episode, Philadelphia-based private equity partner Stephen Leitzell and Washington-based antitrust partner James Fishkin discuss the U.S. Department of Justice’s recent focus on enforcement of Section 8 of the Clayton Act, which prohibits the same person from serving as a director or officer of two competing corporations.

Today's private equity landscape stands in contrast to the anomalous levels of activity in 2021. Rising interest rates, a looming economic downturn and geopolitical tensions have impacted deal activity, yet fundraising and buyouts remain above pre-pandemic levels. How are dealmakers finding creative solutions and opportunities during these uncertain times?  In this special episode of Committe...